185 related articles for article (PubMed ID: 9170045)
1. Evaluation of an ultrasmall superparamagnetic iron oxide in MRI in a bone tumor model in rabbits.
Bush CH; Mladinich CR; Montgomery WJ
J Magn Reson Imaging; 1997; 7(3):579-84. PubMed ID: 9170045
[TBL] [Abstract][Full Text] [Related]
2. Splenic imaging with ultrasmall superparamagnetic iron oxide ferumoxtran-10 (AMI-7227): preliminary observations.
Harisinghani MG; Saini S; Weissleder R; Rubin D; deLange E; Harms S; Weinreb J; Small W; Sukerkar A; Brown JJ; Zelch J; Lucas M; Morris M; Hahn PF
J Comput Assist Tomogr; 2001; 25(5):770-6. PubMed ID: 11584239
[TBL] [Abstract][Full Text] [Related]
3. Lymph node metastasis: ultrasmall superparamagnetic iron oxide-enhanced MR imaging versus PET/CT in a rabbit model.
Choi SH; Moon WK; Hong JH; Son KR; Cho N; Kwon BJ; Lee JJ; Chung JK; Min HS; Park SH
Radiology; 2007 Jan; 242(1):137-43. PubMed ID: 17090719
[TBL] [Abstract][Full Text] [Related]
4. Detection of synovial macrophages in an experimental rabbit model of antigen-induced arthritis: ultrasmall superparamagnetic iron oxide-enhanced MR imaging.
Lutz AM; Seemayer C; Corot C; Gay RE; Goepfert K; Michel BA; Marincek B; Gay S; Weishaupt D
Radiology; 2004 Oct; 233(1):149-57. PubMed ID: 15333767
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow: ultrasmall superparamagnetic iron oxide for MR imaging.
Senéterre E; Weissleder R; Jaramillo D; Reimer P; Lee AS; Brady TJ; Wittenberg J
Radiology; 1991 May; 179(2):529-33. PubMed ID: 2014305
[TBL] [Abstract][Full Text] [Related]
6. Comparison of lymph node metastases assessment with the use of USPIO-enhanced MR imaging at 1.5 T versus 3.0 T in a rabbit model.
Choi SH; Kim KH; Moon WK; Kim HC; Cha JH; Paik JH; Chang KH
J Magn Reson Imaging; 2010 Jan; 31(1):134-41. PubMed ID: 20027581
[TBL] [Abstract][Full Text] [Related]
7. Superparamagnetic iron oxide (SPIO) MRI contrast agent for bone marrow imaging: differentiating bone metastasis and osteomyelitis.
Fukuda Y; Ando K; Ishikura R; Kotoura N; Tsuda N; Kato N; Yoshiya S; Nakao N
Magn Reson Med Sci; 2006 Dec; 5(4):191-6. PubMed ID: 17332709
[TBL] [Abstract][Full Text] [Related]
8. Multicenter clinical trial of ultrasmall superparamagnetic iron oxide in the evaluation of mediastinal lymph nodes in patients with primary lung carcinoma.
Nguyen BC; Stanford W; Thompson BH; Rossi NP; Kernstine KH; Kern JA; Robinson RA; Amorosa JK; Mammone JF; Outwater EK
J Magn Reson Imaging; 1999 Sep; 10(3):468-73. PubMed ID: 10508310
[TBL] [Abstract][Full Text] [Related]
9. Specific targeting of breast tumor by octreotide-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 3.0-Tesla magnetic resonance scanner.
Li X; Du X; Huo T; Liu X; Zhang S; Yuan F
Acta Radiol; 2009 Jul; 50(6):583-94. PubMed ID: 19449236
[TBL] [Abstract][Full Text] [Related]
10. Ultrasmall superparamagnetic iron-oxide-enhanced MR imaging of normal bone marrow in rodents: original research original research.
Simon GH; Raatschen HJ; Wendland MF; von Vopelius-Feldt J; Fu Y; Chen MH; Daldrup-Link HE
Acad Radiol; 2005 Sep; 12(9):1190-7. PubMed ID: 16099684
[TBL] [Abstract][Full Text] [Related]
11. Use of a blood-pool contrast agent for MR-guided vascular procedures: feasibility of ultrasmall superparamagnetic iron oxide particles.
Wacker FK; Wendt M; Ebert W; Hillenbrandt C; Wolf KJ; Lewin JS
Acad Radiol; 2002 Nov; 9(11):1251-4. PubMed ID: 12449357
[TBL] [Abstract][Full Text] [Related]
12. Experimental investigation of the delivery pathway of ultrasmall superparamagnetic iron oxide to lymph nodes.
Frija G; Clément O; Le Guen O; Cuénod CA; Siauve N; Benderbous S
Acad Radiol; 1996 Aug; 3 Suppl 2():S299-300. PubMed ID: 8796586
[No Abstract] [Full Text] [Related]
13. Differences in predominant enhancement mechanisms of superparamagnetic iron oxide and ultrasmall superparamagnetic iron oxide for contrast-enhanced portal magnetic resonance angiography. Preliminary results of an animal study original investigation.
Knollmann FD; Böck JC; Rautenberg K; Beier J; Ebert W; Felix R
Invest Radiol; 1998 Sep; 33(9):637-43. PubMed ID: 9766048
[TBL] [Abstract][Full Text] [Related]
14. Biodistribution of an ultrasmall superparamagnetic iron oxide colloid, BMS 180549, by different routes of administration.
Bengele HH; Palmacci S; Rogers J; Jung CW; Crenshaw J; Josephson L
Magn Reson Imaging; 1994; 12(3):433-42. PubMed ID: 8007773
[TBL] [Abstract][Full Text] [Related]
15. MR lymphography using iron oxide particles. Detection of lymph node metastases in the VX2 rabbit tumor model.
Taupitz M; Wagner S; Hamm B; Dienemann D; Lawaczeck R; Wolf KJ
Acta Radiol; 1993 Jan; 34(1):10-5. PubMed ID: 8427741
[TBL] [Abstract][Full Text] [Related]
16. Detection of focal liver lesions with superparamagnetic iron oxide: value of STIR and SE imaging.
Halavaara JT; Lamminen AE; Bondestam S; Standertskjöld-Nordenstam CG; Hamberg LM
J Comput Assist Tomogr; 1994; 18(6):897-904. PubMed ID: 7962796
[TBL] [Abstract][Full Text] [Related]
17. Positive contrast MR-lymphography using inversion recovery with ON-resonant water suppression (IRON).
Korosoglou G; Tang L; Kedziorek D; Cosby K; Gilson WD; Vonken EJ; Schär M; Sosnovik D; Kraitchman DL; Weiss RG; Weissleder R; Stuber M
J Magn Reson Imaging; 2008 May; 27(5):1175-80. PubMed ID: 18425827
[TBL] [Abstract][Full Text] [Related]
18. Differential uptake of ferumoxtran-10 and ferumoxytol, ultrasmall superparamagnetic iron oxide contrast agents in rabbit: critical determinants of atherosclerotic plaque labeling.
Yancy AD; Olzinski AR; Hu TC; Lenhard SC; Aravindhan K; Gruver SM; Jacobs PM; Willette RN; Jucker BM
J Magn Reson Imaging; 2005 Apr; 21(4):432-42. PubMed ID: 15779033
[TBL] [Abstract][Full Text] [Related]
19. Imaging of macrophages in soft-tissue infection in rats: relationship between ultrasmall superparamagnetic iron oxide dose and MR signal characteristics.
Lutz AM; Weishaupt D; Persohn E; Goepfert K; Froehlich J; Sasse B; Gottschalk J; Marincek B; Kaim AH
Radiology; 2005 Mar; 234(3):765-75. PubMed ID: 15665219
[TBL] [Abstract][Full Text] [Related]
20. Macrophage activity in infected areas of an experimental vertebral osteomyelitis model: USPIO-enhanced MR imaging--feasibility study.
Bierry G; Jehl F; Boehm N; Robert P; Prévost G; Dietemann JL; Desal H; Kremer S
Radiology; 2008 Jul; 248(1):114-23. PubMed ID: 18458246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
